| Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89. 6P) A Cafaro, F Titti, C Fracasso, MT Maggiorella, S Baroncelli, A Caputo, ... Vaccine 19 (20-22), 2862-2877, 2001 | 179 | 2001 |
| IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils V Lucarini, G Ziccheddu, I Macchia, V La Sorsa, F Peschiaroli, C Buccione, ... Oncoimmunology 6 (6), e1317420, 2017 | 170 | 2017 |
| Long-term protection against SHIV89. 6P replication in HIV-1 Tat vaccinated cynomolgus monkeys MT Maggiorella, S Baroncelli, Z Michelini, E Fanales-Belasio, S Moretti, ... Vaccine 22 (25-26), 3258-3269, 2004 | 100 | 2004 |
| Unraveling cancer chemoimmunotherapy mechanisms by gene and protein expression profiling of responses to cyclophosphamide F Moschella, M Valentini, E Aricò, I Macchia, P Sestili, MT D'Urso, ... Cancer research 71 (10), 3528-3539, 2011 | 92 | 2011 |
| Combining type i interferons and 5-aza-2′-deoxycitidine to improve anti-tumor response against melanoma V Lucarini, C Buccione, G Ziccheddu, F Peschiaroli, P Sestili, R Puglisi, ... Journal of Investigative Dermatology 137 (1), 159-169, 2017 | 77 | 2017 |
| HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection E Fanales-Belasio, S Moretti, V Fiorelli, A Tripiciano, MR Pavone Cossut, ... The Journal of Immunology 182 (5), 2888-2897, 2009 | 71 | 2009 |
| SHIV89. 6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine A Cafaro, A Caputo, MT Maggiorella, S Baroncelli, C Fracasso, M Pace, ... Journal of Medical Primatology 29 (3‐4), 193-208, 2000 | 71 | 2000 |
| HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies P Monini, A Cafaro, IK Srivastava, S Moretti, VA Sharma, C Andreini, ... PLoS One 7 (11), e48781, 2012 | 65 | 2012 |
| HIV-1 Tat-based vaccines: from basic science to clinical trials E Fanales-Belasio, A Cafaro, A Cara, DRM Negri, V Fiorelli, S Butto, ... DNA and cell biology 21 (9), 599-610, 2002 | 62 | 2002 |
| Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma C Rozera, GA Cappellini, G D’Agostino, L Santodonato, L Castiello, ... Journal of translational medicine 13, 1-13, 2015 | 37 | 2015 |
| Transduction of Human Antigen-Presenting Cells with Integrase-Defective Lentiviral Vector Enables Functional Expansion of Primed Antigen-Specific CD8+ T Cells DRM Negri, R Bona, Z Michelini, P Leone, I Macchia, ME Klotman, ... Human gene therapy 21 (8), 1029-1035, 2010 | 37 | 2010 |
| Expression of CD8α identifies a distinct subset of effector memory CD4+ T lymphocytes I Macchia, MC Gauduin, A Kaur, RP Johnson Immunology 119 (2), 232-242, 2006 | 31 | 2006 |
| Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigen L Sernicola, F Corrias, ML Koanga-Mogtomo, S Baroncelli, S Di Fabio, ... Virology 256 (2), 291-302, 1999 | 30 | 1999 |
| Immune monitoring in cancer vaccine clinical trials: critical issues of functional flow cytometry-based assays I Macchia, F Urbani, E Proietti BioMed research international 2013, 2013 | 28 | 2013 |
| Increased replication of Sendai virus in morphine-treated epithelial cells: evidence for the involvement of the intracellular levels of glutathione I Macchia, AT Palamara, C Bué, P Savini, M Ciriolo, R Gaziano, ... International journal of immunopharmacology 21 (3), 185-193, 1999 | 28 | 1999 |
| Containment of Infection in Tat Vaccinated Monkeys After Rechallenge with a Higher Dose of SHIV89.6Pcy243 A Borsetti, S Baroncelli, MT Maggiorella, S Moretti, E Fanales-Belasio, ... Viral immunology 22 (2), 117-124, 2009 | 27 | 2009 |
| Mechanisms of action of ozone therapy in emerging viral diseases: Immunomodulatory effects and therapeutic advantages with reference to SARS-CoV-2 A Cenci, I Macchia, V La Sorsa, C Sbarigia, V Di Donna, D Pietraforte Frontiers in Microbiology 13, 871645, 2022 | 26 | 2022 |
| Multiprotein genetic vaccine in the SIV‐Macaca animal model: a promising approach to generate sterilizing immunity to HIV infection MT Maggiorella, L Sernicola, F Crostarosa, R Belli, MR Pavone‐Cossut, ... Journal of medical primatology 36 (4‐5), 180-194, 2007 | 23 | 2007 |
| Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccine C Lapenta, S Donati, F Spadaro, L Lattanzi, F Urbani, I Macchia, P Sestili, ... Cancer Immunology, Immunotherapy 68 (11), 1791-1804, 2019 | 22 | 2019 |
| Innovative approaches to develop prophylactic and therapeutic vaccines against HIV/AIDS A Cafaro, I Macchia, MT Maggiorella, F Titti, B Ensoli Pharmaceutical Biotechnology, 189-242, 2009 | 18 | 2009 |
